Clinical Trials in Detroit

Showing 3341-3360 of 9,449 trials

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

NCT04377945

This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.

DyskinesiasParkinson Disease

Bukwang Pharmaceutical41 participantsStarted Apr 2021

Miami, Florida, United States • Detroit, Michigan, United States

Active Not RecruitingNA< 1 mile

Rapid Adaptation to Prevent Drug Use

NCT05806840

Using a 2-group, mixed method cluster randomized trial design, this study will compare standard implementation versus RAPD implementation strategy in Michigan Middle Schools

Substance Use

Wayne State University12 participantsStarted Sep 2023

Detroit, Michigan, United States

TERMINATEDPhase 1/2< 1 mile

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

NCT04161391

A phase 1/2, first-in-human, open-label study to determine the safety, tolerability, PK, and preliminary efficacy of the novel RET/SRC inhibitor TPX-0046 in adult subjects with advanced or metastatic solid tumors harboring RET mutations or alterations. The study consists of three portions: 1) Phase 1 Dose Escalation and Food Effect Sub-study, and 2) Phase 1 dose expansion and 3) Phase 2 efficacy evaluation.

Non Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more

Turning Point Therapeutics, Inc.41 participantsStarted Dec 2019

La Jolla, California, United States • Orange, California, United States • Aurora, Colorado, United States +18 more locations

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

Rapid Adaptation to Prevent Drug Use

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Find Trials by Condition in Detroit

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

Open-Label Study of Oral Treprostinil in Digital Ulcers

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

Epacadostat and Pembrolizumab in Patients With GIST

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Investigating Gains in Neurocognition in an Intervention Trial of Exercise

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

A Study of Replagal in Treatment-naïve Adults With Fabry Disease